Alcon Research, LLC, Fort Worth, Texas.
College of Optometry, University of Houston, Houston, Texas.
Optom Vis Sci. 2020 Aug;97(8):565-572. doi: 10.1097/OPX.0000000000001553.
Lotrafilcon B lenses packaged in and cared for with block copolymer-containing (polyoxyethylene-polyoxybutylene; EOBO) lens care solutions resulted in lower cholesterol extraction than each of the habitual silicone hydrogel lens/multipurpose solution (MPS) regimens tested.
This study aimed to compare the extracted cholesterol of lotrafilcon B lenses packaged in and cared for with EOBO-containing lens care solutions with the extracted cholesterol of habitual silicone hydrogel lenses cared for with MPS not containing EOBO.
In this prospective, randomized, observer-masked parallel study, habitual wearers of senofilcon C, senofilcon A, comfilcon A, and samfilcon A contact lenses using a non-EOBO MPS were randomized 1:1 to lotrafilcon B lenses packaged in and cared for with EOBO-containing solutions or to their habitual lenses and MPS. Subjects randomized to lotrafilcon B were further randomized to one of two EOBO-containing lens care solutions, OPTI-FREE PUREMOIST or CLEAR CARE PLUS with HydraGlyde (Alcon Laboratories, Inc., Fort Worth, TX). A subset of right eye lenses was collected after wear, and total cholesterol was extracted and measured using a fluorometric enzymatic assay.
Of 143 lenses analyzed, 95 were from subjects randomized to their habitual lenses/MPS and 48 to lotrafilcon B + EOBO lenses plus CLEAR CARE PLUS with HydraGlyde or OPTI-FREE PUREMOIST. The mean amounts of cholesterol extracted from lotrafilcon B + EOBO lenses cared for with CLEAR CARE PLUS with HydraGlyde (0.28 ± 0.18 μg/lens) and OPTI-FREE PUREMOIST (0.28 ± 0.48 μg/lens) were significantly lower than those extracted from senofilcon C (4.18 ± 3.25 μg/lens), senofilcon A (2.19 ± 2.69 μg/lens), comfilcon A (2.17 ± 1.47 μg/lens), and samfilcon A (2.07 ± 1.48 μg/lens) lenses used with MPS (P < .0001 each).
Cholesterol sorption was significantly lower in wearers of lotrafilcon B lenses cared for with polyoxyethylene-polyoxybutylene-containing lens care solutions than in users of habitual silicone hydrogel lenses cared for with non-polyoxyethylene-polyoxybutylene MPS.
与含有嵌段共聚物(聚氧乙烯-聚氧丁烯;EOBO)的隐形眼镜护理液一起包装和护理的乐透菲康 B 镜片,从每种测试的惯用硅水凝胶镜片/多功能溶液(MPS)方案中提取的胆固醇要少。
本研究旨在比较含有 EOBO 的隐形眼镜护理液包装和护理的乐透菲康 B 镜片与不含 EOBO 的 MPS 护理的惯用硅水凝胶镜片提取的胆固醇。
在这项前瞻性、随机、观察者盲法平行研究中,使用非 EOBO MPS 的 senofilcon C、senofilcon A、comfilcon A 和 samfilcon A 隐形眼镜的习惯性佩戴者按 1:1 随机分为乐透菲康 B 镜片包装和护理用 EOBO 隐形眼镜护理液或其惯用镜片和 MPS。随机分配给乐透菲康 B 的受试者进一步随机分为两种 EOBO 隐形眼镜护理液之一,OPTIFREE PUREMOIST 或含有 HydraGlyde 的 CLEAR CARE PLUS(爱尔康实验室,沃思堡,德克萨斯州)。在佩戴后收集右眼镜片的一小部分,使用荧光酶法测定提取和测量总胆固醇。
在分析的 143 个镜片中,95 个来自随机分配到其惯用镜片/MPS 的受试者,48 个来自乐透菲康 B+EOBO 镜片加 CLEAR CARE PLUS 与 HydraGlyde 或 OPTIFREE PUREMOIST。用 CLEAR CARE PLUS 与 HydraGlyde(0.28±0.18μg/镜片)和 OPTIFREE PUREMOIST(0.28±0.48μg/镜片)护理的乐透菲康 B+EOBO 镜片提取的胆固醇量明显低于用 MPS 护理的 senofilcon C(4.18±3.25μg/镜片)、senofilcon A(2.19±2.69μg/镜片)、comfilcon A(2.17±1.47μg/镜片)和 samfilcon A(2.07±1.48μg/镜片)(P<0.0001)。
与使用非聚氧乙烯-聚氧丁烯 MPS 护理的惯用硅水凝胶镜片使用者相比,使用含有聚氧乙烯-聚氧丁烯的隐形眼镜护理液护理的乐透菲康 B 镜片的胆固醇吸附率明显降低。